REVIEW
Published on 05 Aug 2021
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
doi 10.3389/fphar.2021.518345
- 6,946 views
- 21 citations
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
12k
Total downloads
68k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
EDITORIAL
Published on 12 Apr 2021
Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
doi 10.3389/fphar.2021.657596
- 1,223 views
- 2 citations
MINI REVIEW
Published on 22 Jul 2020
Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
doi 10.3389/fphar.2020.01135
- 3,034 views
- 10 citations
REVIEW
Published on 06 May 2020
Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors
doi 10.3389/fphar.2020.00609
- 9,845 views
- 25 citations
ORIGINAL RESEARCH
Published on 01 May 2020
PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells
doi 10.3389/fphar.2020.00470
- 3,717 views
- 15 citations
MINI REVIEW
Published on 12 Mar 2020
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
doi 10.3389/fphar.2020.00259
- 41,449 views
- 86 citations
ORIGINAL RESEARCH
Published on 12 Nov 2019
CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice
doi 10.3389/fphar.2019.01337
- 2,681 views
- 7 citations
Published in
Frontiers in Pharmacology
- Respiratory Pharmacology
Impact
- 68kTopic views
- 54kArticle views
- 12kArticle downloads